Skip to main content
Clinical Trials/TCTR20210510002
TCTR20210510002
Not Yet Recruiting
Phase 3

A prospective cohort study of nutritional status and uremic toxin removal during long-term periods of super high-flux hemodialysis in chronic hemodialysis patients and the effect of RNA sequencing on peripheral blood mononuclear cells

Faculty of medicine, Naresuan University0 sites15 target enrollmentMay 10, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
End stage kidney disease required hemodialysis (Prevalence case)
Sponsor
Faculty of medicine, Naresuan University
Enrollment
15
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2021
End Date
June 30, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of medicine, Naresuan University

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years old
  • Prevalence case of hemodialysis at least 3 months
  • Hemodialysis 3 times/week with adequate Kt/V \> 1\.2
  • Serum albumin \> 3 mg/dL
  • Vascular access are eligible for blood flow rate \> 400 ml/min
  • Adequate dry weight with BCM \+/\- OH 2 kg
  • Hemodynamic stability more than 2 weeks
  • Inform consent

Exclusion Criteria

  • Chronic infection or active cardiovascular diseases 3 month prior to recruitment
  • Metastasis malignancy
  • Advance cirrhosis
  • Hemodynamic instability
  • Contraindication to anticoagulant
  • Refuse to informed consent
  • Serum albumin levels \< 3 mg/d

Outcomes

Primary Outcomes

Not specified

Similar Trials